Although this study represents a first-in-human investigation into the safety and efficacy of LNP treatment for a rare disease, it is not without limitations. These include a small sample size for each cohort, the absence of a control group, the open-label nature of the study design and the...
ENDORSED BY:Australasian Leukaemia and Lymphoma Group; Australasian Lung Cancer Trials Group; Australian and New Zealand Children's Haematology/Oncology Group; Australia and New Zealand Society of Palliative Medicine; Australasian Society for Infectious Diseases; Bone Marrow Transplantation Society of ...
Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC: Prevalence of kidney damage in australian adults: the AusDiab kidney study. J Am Soc Nephrol. 2003, 14 (7 Suppl 2): S131-S138. Article PubMed Google Scholar Zhang QL, Rothenbacher D: Prevalence of...